Cryo-Cell International's Total Assets for the quarter that ended in Feb. 2024 was $61.71 Mil.
During the past 12 months, Cryo-Cell International's average Total Assets Growth Rate was -5.00% per year.
During the past 3 years, the average Total Assets Growth Rate was 19.00% per year.
During the past 5 years, the average Total Assets Growth Rate was 14.60% per year.
During the past 10 years, the average Total Assets Growth Rate was 26.10% per year.
During the past 13 years, Cryo-Cell International's highest 3-Year average Total Assets Growth Rate was 53.60%. The lowest was -17.80%. And the median was 15.10%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Cryo-Cell International's Total Assets for the fiscal year that ended in Nov. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryo-Cell International (AMEX:CCEL) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Feb. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Cryo-Cell International's Asset Turnover for the quarter that ended in Feb. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Cryo-Cell International Total Assets Related Terms
Thank you for viewing the detailed overview of Cryo-Cell International's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Cryo-Cell International (Cryo-Cell International) Business Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CCEL has been successfully added to your 